1. Home
  2. STRO vs LEGT Comparison

STRO vs LEGT Comparison

Compare STRO & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • LEGT
  • Stock Information
  • Founded
  • STRO 2003
  • LEGT 2023
  • Country
  • STRO United States
  • LEGT United States
  • Employees
  • STRO N/A
  • LEGT N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • LEGT
  • Sector
  • STRO Health Care
  • LEGT
  • Exchange
  • STRO Nasdaq
  • LEGT Nasdaq
  • Market Cap
  • STRO 292.6M
  • LEGT 263.0M
  • IPO Year
  • STRO 2018
  • LEGT 2024
  • Fundamental
  • Price
  • STRO $4.22
  • LEGT $10.27
  • Analyst Decision
  • STRO Strong Buy
  • LEGT
  • Analyst Count
  • STRO 7
  • LEGT 0
  • Target Price
  • STRO $12.14
  • LEGT N/A
  • AVG Volume (30 Days)
  • STRO 506.3K
  • LEGT 63.7K
  • Earning Date
  • STRO 11-19-2024
  • LEGT 01-01-0001
  • Dividend Yield
  • STRO N/A
  • LEGT N/A
  • EPS Growth
  • STRO N/A
  • LEGT N/A
  • EPS
  • STRO N/A
  • LEGT N/A
  • Revenue
  • STRO $169,359,000.00
  • LEGT N/A
  • Revenue This Year
  • STRO N/A
  • LEGT N/A
  • Revenue Next Year
  • STRO N/A
  • LEGT N/A
  • P/E Ratio
  • STRO N/A
  • LEGT N/A
  • Revenue Growth
  • STRO 197.83
  • LEGT N/A
  • 52 Week Low
  • STRO $2.06
  • LEGT $10.00
  • 52 Week High
  • STRO $6.13
  • LEGT $10.47
  • Technical
  • Relative Strength Index (RSI)
  • STRO 60.47
  • LEGT N/A
  • Support Level
  • STRO $4.08
  • LEGT N/A
  • Resistance Level
  • STRO $4.60
  • LEGT N/A
  • Average True Range (ATR)
  • STRO 0.28
  • LEGT 0.00
  • MACD
  • STRO 0.08
  • LEGT 0.00
  • Stochastic Oscillator
  • STRO 72.46
  • LEGT 0.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

Share on Social Networks: